Wockhardt gets nod to raise up to Rs 2200 crore

05 May 2017 Evaluate

Wockhardt has received its board’s approval to raise up to Rs 2200 crore through equity and debt instruments. The company has decided to raise up to Rs 1200 crore through issuance of non-convertible debentures (NCDs) on a private placement basis and up to Rs 1000 crore through equity instruments, including qualified institutional placement (QIP) of shares.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1345.90 -17.25 (-1.27%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×